224 related articles for article (PubMed ID: 3975346)
1. Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome.
Walker RG; Scheinkestel C; Becker GJ; Owen JE; Dowling JP; Kincaid-Smith P
Q J Med; 1985 Jan; 54(213):75-89. PubMed ID: 3975346
[TBL] [Abstract][Full Text] [Related]
2. [Anti-basement-membrane antibody mediated, rapidly progressive, glomerulonephritis. Diagnostic and therapeutic strategy based on a retrospective study of 14 cases].
Bouget J; Le Pogamp P; Perrier G; Ramée MP; Rivalan J; Camus C; Thomas R; Chevet D
Ann Med Interne (Paris); 1990; 141(5):409-15. PubMed ID: 2256583
[TBL] [Abstract][Full Text] [Related]
3. The clinical spectrum of acute glomerulonephritis and lung haemorrhage (Goodpasture's syndrome).
Holdsworth S; Boyce N; Thomson NM; Atkins RC
Q J Med; 1985 Apr; 55(216):75-86. PubMed ID: 4011844
[TBL] [Abstract][Full Text] [Related]
4. Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 cases.
Merkel F; Pullig O; Marx M; Netzer KO; Weber M
Nephrol Dial Transplant; 1994; 9(4):372-6. PubMed ID: 8084449
[TBL] [Abstract][Full Text] [Related]
5. Incidence and features of dual anti-GBM-positive and ANCA-positive patients.
DE Zoysa J; Taylor D; Thein H; Yehia M
Nephrology (Carlton); 2011 Nov; 16(8):725-9. PubMed ID: 21649794
[TBL] [Abstract][Full Text] [Related]
6. Two cases of Goodpasture's syndrome--clinicopathological studies and relapse.
Kojima K; Okada Y; Kushimoto H; Kawamura N; Katsumata H; Murakami K; Yamasita H; Tomita M; Hasegawa M; Yanai T
Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):89-96. PubMed ID: 8336406
[TBL] [Abstract][Full Text] [Related]
7. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Goodpasture's disease by plasma exchange and immunosuppression.
Swainson CP; Robson JS; Urbaniak SJ; Keller AJ; Kay AB
Clin Exp Immunol; 1978 May; 32(2):233-42. PubMed ID: 668199
[TBL] [Abstract][Full Text] [Related]
9. Failure of plasma exchange and immunosuppression to improve renal function in Goodpasture's syndrome.
McLeish KR; Maxwell DR; Luft FC
Clin Nephrol; 1978 Aug; 10(2):71-3. PubMed ID: 699402
[TBL] [Abstract][Full Text] [Related]
10. Transplantation, immunosuppression and plasmapheresis in Goodpasture's syndrome.
Cove-Smith JR; McLeod AA; Blamey RW; Knapp MS; Reeves WG; Wilson CB
Clin Nephrol; 1978 Mar; 9(3):126-8. PubMed ID: 346273
[TBL] [Abstract][Full Text] [Related]
11. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease.
Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY
Nephrol Dial Transplant; 2009 Jun; 24(6):1838-44. PubMed ID: 19151145
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcal protein A immunoadsorption for Goodpasture's syndrome in four Chinese patients.
Hu W; Liu Z; Ji D; Xie H; Gong D; Li L
J Nephrol; 2006; 19(3):312-7. PubMed ID: 16874690
[TBL] [Abstract][Full Text] [Related]
13. Immunoadsorption in Goodpasture's syndrome.
Laczika K; Knapp S; Derfler K; Soleiman A; Hörl WH; Druml W
Am J Kidney Dis; 2000 Aug; 36(2):392-5. PubMed ID: 10922318
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and outcomes of patients with Goodpasture's syndrome.
Shah MK; Hugghins SY
South Med J; 2002 Dec; 95(12):1411-8. PubMed ID: 12597309
[TBL] [Abstract][Full Text] [Related]
15. Still a role for plasma exchange in rapidly progressive glomerulonephritis?
Levy JB; Pusey CD
J Nephrol; 1997; 10(1):7-13. PubMed ID: 9241619
[TBL] [Abstract][Full Text] [Related]
16. Goodpasture's syndrome with normal renal function.
Bailey RR; Simpson IJ; Lynn KL; Neale TJ; Doak PB; McGiven AR
Clin Nephrol; 1981 Apr; 15(4):211-5. PubMed ID: 7237870
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of circulating anti-glomerular basement membrane antibody three years after immunosuppressive treatment and plasma exchange.
Hind CR; Bowman C; Winearls CG; Lockwood CM
Clin Nephrol; 1984 Apr; 21(4):244-6. PubMed ID: 6733989
[TBL] [Abstract][Full Text] [Related]
19. [A clinical and pathological analysis of 41 patients with anti-glomerular basement membrane antibody related diseases].
Zhao M; Ding J; Liu Y; Zou W; Wang H
Zhonghua Nei Ke Za Zhi; 2001 May; 40(5):316-20. PubMed ID: 11798594
[TBL] [Abstract][Full Text] [Related]
20. A case report of efficiency of double filtration plasmapheresis in treatment of Goodpasture's syndrome.
Hajime N; Michiko A; Atsunori K; Tatsuo K; Yuko N; Naoki O; Katsuhiko S
Ther Apher Dial; 2009 Aug; 13(4):373-7. PubMed ID: 19695077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
